Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  cisplatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 2662 for your search:
Start Over
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: AGOSG-OVAR-MO16375-MARCH, CDR0000257189, EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 97-02-12, NCT00686322
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-13, NCT00911092
Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: CH-BC-008, NCT01143974
A Study of Second-Line Therapy With Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML29028, NCT02000531
Phase II/III Randomized Study of CDDP/5-FU vs CDDP/5-FU/IFN-A for Metastatic Pancreatic Cancer (Summary Last Modified 02/95)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-40924
Combination Chemotherapy in Treating Men With Germ Cell Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 to 50
Sponsor: Other
Protocol IDs: EORTC-30983, NCT00003643
Phase II-III Chemotherapy with CAP (CTX/ADR/CACP) vs AMSA for Advanced Transitional Cell Cancer of the Urinary Bladder (Summary Last Modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7922
Phase II/III cis-Platinum in 2-Drug and 3-Drug Combinations with VP-16 and DAVA for Advanced non-Oat Cell Carcinoma of the Lung
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8075, NCI-D81-043-098
Master Protocol to Compare MTX/5-FU vs CACP/5-FU vs Phase II Agent for Squamous Cell Cancer of the Head and Neck (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8223/24/25, SWOG-8224, SWOG-8225
Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8380
Phase II/III Chemotherapy with MTX vs MTX/CACP for Patients with Regionally Advanced or Metastatic Carcinoma of the Urinary Bladder
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-14
Phase II/III Chemotherapy with CAMP (CTX/ADR/MTX/PCB) vs VP-16/DAVA/CACP vs VP-16/CACP vs DAVA/CACP for Stage III Metastatic non-Small Cell Bronchogenic Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
Phase II/III Combination Chemotherapy with VP-16213/CTX/CACP in Patients with Stage II/III Testicular Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: NCI-D82-043-188, MDA-IM-8104
Phase II/III Comparison of the Platinum Compounds CBDCA vs CHIP vs CACP for Recurrent or Metastatic Epidermoid Carcinoma of the Head and Neck
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8223
Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-834151, MAYO-834151, NCCTG-83-41-51
Phase II/III Induction Chemotherapy with CACP/BLEO/MTX/CF vs CACP/5-FU for Stage II/III/IV, Previously Untreated Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 09/88)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-83084, NCI-T84-0282D, T84-0282
Phase II/III Chemotherapy with Intraperitoneal CDDP in Patients with Ovarian Carcinoma Limited to the Peritoneal Cavity
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCLA-81021523, NCI-V83-0303
Start Over